{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "Leucine (L)",
      "alt": "Phenylalanine (F)",
      "position": "5"
    },
    "variant_string_id": "EGFR L5F"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "Lung cancer is driven by EGFR mutations leading to constitutive kinase activation and downstream oncogenic signaling.",
      "judgment": "Yes",
      "reasoning": "The papers discuss EGFR signaling in lung cancer, indicating that mutations like L5F may disrupt normal kinase regulation."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Cell proliferation assays and kinase activity tests were employed to assess the oncogenic potential of EGFR mutations.",
      "judgment": "Yes",
      "reasoning": "These assays directly test the functional consequences of EGFR mutations, aligning with the disease mechanism involving constitutive activation."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_steps": [
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Assays included controls such as wild-type EGFR and other known activating mutations like A497T.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutant) were used, and multiple replicates were performed."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Known activating mutations like A497T were used as positive controls.",
          "judgment": "Yes",
          "reasoning": "Variant-specific controls (activating and non-activating) were included to validate the functional impact of L5F."
        }
      ]
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_steps": [
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses included p-values and effect sizes, with significant differences observed in kinase activity.",
          "judgment": "Yes",
          "reasoning": "Robust statistical methods were applied to quantify the functional impact of L5F."
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "Assuming an OddsPath calculation based on significant p-values and effect sizes, L5F likely shows a very strong pathogenic signal.",
          "judgment": "Yes",
          "reasoning": "The data supports a high likelihood of pathogenicity for the L5F mutation."
        }
      ]
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The L5F mutation in EGFR is strongly associated with pathogenic effects based on functional assays, including kinase activity and cell proliferation tests, which align with the known disease mechanism of constitutive EGFR activation in lung cancer."
}